Document 0522
 DOCN  M9650522
 TI    Seroprevalence and risk factors associated with HTLV-I/II infection in
       injection drug users in northern New Jersey.
 DT    9605
 AU    Freeman RC; Rodriguez GM; French JF; New Jersey State Department of
       Health, Division of Alcoholism,; Drug Abuse, and Addiction Services,
       Newark, USA.
 SO    J Addict Dis. 1995;14(3):51-66. Unique Identifier : AIDSLINE
       MED/96127013
 AB    Data from an AIDS Demonstration Research project in Paterson, NJ, that
       enrolled out-of-treatment injection drug users (IDUs) were analyzed to
       detect demographic patterns and risk factors associated with infection
       with human immunodeficiency virus (HIV) and human T-lymphotropic virus
       types I or II (HTLV-I/II). Of 410 IDUs screened, 44.2% were HIV-positive
       and 19.3% were HTLV-I/II-positive. African-Americans were significantly
       more likely than other racial groups to be HTLV-I/II-seropositive and to
       be HIV-seropositive. Over one-fifth of African-Americans--but no Latinos
       or whites--were doubly infected with HIV and HTLV-I/II. In logistic
       regression analysis, African-American race, long-term injection drug
       use, and age were significant predictors of HTLV-I/II-seropositivity.
       While the associations between recent needle practices and
       HTLV-I/II-seropositivity fell short of significance, the trends in the
       data were consistent with a hypothesis that HTLV-I/II is transmitted
       through the sharing of injection equipment. Public health implications
       of the data are discussed.
 DE    Adolescence  Adult  Aged  Comparative Study  Human  HTLV-BLV
       Infections/BLOOD/*COMPLICATIONS/VIROLOGY  HTLV-I/*ISOLATION & PURIF
       HTLV-II/*ISOLATION & PURIF  Middle Age  Racial Stocks  Sex Factors
       Substance Abuse, Intravenous/*COMPLICATIONS  Support, U.S. Gov't, P.H.S.
       JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).